| Literature DB >> 28678776 |
Tian Hua1,2,3, Kiran Vemuri4, Spyros P Nikas4, Robert B Laprairie5, Yiran Wu1, Lu Qu1,2,3, Mengchen Pu1, Anisha Korde4, Shan Jiang4, Jo-Hao Ho5, Gye Won Han6, Kang Ding1,3,7, Xuanxuan Li8, Haiguang Liu8, Michael A Hanson9, Suwen Zhao1,7, Laura M Bohn5, Alexandros Makriyannis4, Raymond C Stevens1,6,7, Zhi-Jie Liu1,2,7.
Abstract
The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC). Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resolution, respectively. The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region. In addition, a 'twin toggle switch' of Phe2003.36 and Trp3566.48 (superscripts denote Ballesteros-Weinstein numbering) is experimentally observed and appears to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28678776 PMCID: PMC5793864 DOI: 10.1038/nature23272
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962